Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab with Eldecalcitol for Postmenopausal Osteoporosis
NCT05884372Phase 4Completed
- Sponsor
- Xi'an Honghui Hospital
- Start
- Aug 2023
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of eldecalcitol in postmenopausal osteoporosis, sponsored by Xi'an Honghui Hospital. Started Aug 2023; status: completed.
02
Drugs
eldecalcitol
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT05884372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05884372.